Researcher
Bouke de Jong
Affiliations
- Mycobacteriology (Research unit)
Member
From1 Sep 2010 → Today - Mycobacteriology (Research unit)
Member
From31 Aug 2010 → 16 Apr 2015
Projects
1 - 10 of 75
- Culturing from Tongue SwabsFrom12 Dec 2022 → 15 Dec 2023
- Omics Data Integration to Predict Drug Resistance in Mycobacterium tuberculosisFrom27 Apr 2022 → Today
- Make Rwandan institutes leaders in infectious disease prevention, diagnosis and controlFrom1 Jan 2022 → Today
- Rapid diagnosis of Mycobacterium tuberculosis resistance, beyond rifampicinFrom1 Jan 2022 → Today
- Consolidation and management of the BCCM Consortium as a "Belgian Research Center".From1 Jan 2022 → Today
- TB/NTM Research ClusterFrom1 Jan 2022 → Today
- Multi Omics Data Integration to predict the M. tuberculosis Bedaquiline Resistance Phenotype from the GenotypeFrom1 Jan 2022 → Today
- Strengthen research and education capacities in the partner institutes (INRB, CRSK, ESP) in DRC (Outcome 1) - Support to interruption of transmission of Human African Trypanosomiasis (HAT) by 2030 (Outcome 2)From1 Jan 2022 → Today
- Culture-free approaches including whole genome sequencing in support of diagnostic and transmission studies on Mycobacterium lepraeFrom30 Jun 2021 → Today
- Curbing rifampicin-resistant tuberculosis in Rwanda and beyondFrom30 Jun 2021 → Today
Publications
41 - 50 of 167
- Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial(2021)
Authors: L. Guglielmetti, Elisa Ardizzoni, M. Atger, E. Baudin, E. Berikova, M. Bonnet, E. Chang, Sandrine Cloez, J. M. Coit, J Cox, et al.
- Genetic diversity of the Mycobacterium tuberculosiscomplex strains from newly diagnosed tuberculosis patients in Northwest Ethiopia reveals a predominance of East-African-Indian and Euro-American lineages(2021)
Authors: Mebrat Ejo Kitata, Cécile Uwizeye, Meseret Kassa, Yilak Girma, Tiruzer Bekele, Yilkal Ademe, Ermias Diro, Florian Gehre, Leen Rigouts, Bouke de Jong
Pages: 72-80 - Rifampicin-resistant tuberculosis treatment: way forward without hampering future options?(2021)
Authors: Tom Decroo, Anita Mesic, Bouke de Jong, Leen Rigouts, Tinne Gils, J. Mallick, Lut Lynen
Pages: 255-255 - High-dose first-line treatment regimen for recurrent rifampicin-susceptible tuberculosis(2020)
Authors: Tom Decroo, Bouke C de Jong, Alberto Piubello, Mahamadou Bassirou Souleymane, Lut Lynen, Armand Van Deun
Pages: 1578-1579 - Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes(2020)
Authors: Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Cécile Uwizeye, Mourad Gumusboga, Tine Demeulenaere, Nimer Ortuno-Gutierrez, Bouke de Jong, Armand Van Deun
- First-line tuberculosis treatment with double-dose rifampicin is well tolerated(2020)
Authors: A.K.J. Maug, M.A. Hossain, Mourad Gumusboga, Tom Decroo, Wim Mulders, Sofie Braet, Jozefien Buyze, Diana Arango, Céline Schurmans, Natacha Herssens, et al.
Pages: 499-505 - Comparative genomics shows differences in the electron transport and carbon metabolic pathways of Mycobacterium africanum relative to Mycobacterium tuberculosis and suggests an adaptation to low oxygen tension(2020)
Authors: Nana Akua Boatema Ofori-Anyinam, Abi Janet Riley, Tijan Jobarteh, Ensa Gitteh, Binta Sarr, Tutty Isatou Faal-Jawara, Leen Rigouts, Madikay Senghore, Aderemi Kehinde, Nneka Onyejepu, et al.
- Characterization of Mycobacterium tuberculosis var. africanum isolated from a patient with pulmonary tuberculosis in Brazil(2020)
Authors: Marcelo Fouad Rabahi, Emilyn Costa Conceicao, Luisa Oliveira de Paiva, Marcos Vinicius Muniz Lemes Souto, Maria Carolina Sisco, Jacobus de Waard, Paulo Cesar de Souza Caldas, Fatima Fandinho, Jesus Pais Ramos, Luciana Distasio de Carvalho, et al.
- Introduction of Mycobacterium ulcerans disease in the Bankim Health District of Cameroon follows damming of the Mape River(2020)
Authors: Koen Vandelannoote, Gerd Pluschke, Miriam Bolz, Martin W Bratschi, Sarah Kerber, Timothy P Stinear, Bouke de Jong
- Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda(2020)
Authors: Jean Claude Semuto Ngabonziza, Tom Decroo, Patrick Migambi, Yves Mucyo Habimana, Armand Van Deun, Conor J. Meehan, Gabriela Torrea, Faridath Massou, Willem Bram de Rijk, Bertin Ushizimpumu, et al.
Pages: E74-E83